Intracellular toll-like receptors.
暂无分享,去创建一个
[1] B. Beutler,et al. A mutation of Ikbkg causes immune deficiency without impairing degradation of IκBα , 2010, Proceedings of the National Academy of Sciences.
[2] S. Ildstad,et al. Plasmacytoid Dendritic Cells Regulate Autoreactive B Cell Activation via Soluble Factors and in a Cell-to-Cell Contact Manner1 , 2009, The Journal of Immunology.
[3] S. Maschalidi,et al. Critical role for asparagine endopeptidase in endocytic Toll-like receptor signaling in dendritic cells. , 2009, Immunity.
[4] Himanshu Kumar,et al. Toll-like receptors and innate immunity. , 2009, Biochemical and biophysical research communications.
[5] I. Schwartz,et al. Recognition of Borrelia burgdorferi, the Lyme Disease Spirochete, by TLR7 and TLR9 Induces a Type I IFN Response by Human Immune Cells1 , 2009, The Journal of Immunology.
[6] R. Locksley,et al. Toll-like receptor 2 on inflammatory monocytes induces type I interferon in response to viral but not bacterial ligands , 2009, Nature Immunology.
[7] M. Binder,et al. Bacterial RNA is recognized by different sets of immunoreceptors , 2009, European journal of immunology.
[8] J. Di Domizio,et al. TLR7 stimulation in human plasmacytoid dendritic cells leads to the induction of early IFN-inducible genes in the absence of type I IFN. , 2009, Blood.
[9] Thomas F. Tedder,et al. Innate and Adaptive Immunity Cooperate Flexibly to Maintain Host-Microbiota Mutualism , 2009, Science.
[10] M. Oyama,et al. Unc93B1 biases Toll-like receptor responses to nucleic acid in dendritic cells toward DNA- but against RNA-sensing , 2009, The Journal of experimental medicine.
[11] Zhijian J. Chen,et al. The role of ubiquitin in NF-kappaB regulatory pathways. , 2009, Annual review of biochemistry.
[12] S. Akira,et al. Bacterial recognition by TLR7 in the lysosomes of conventional dendritic cells , 2009, Nature Immunology.
[13] D. Golenbock,et al. TAG, a splice variant of the adaptor TRAM, negatively regulates the adaptor MyD88–independent TLR4 pathway , 2009, Nature Immunology.
[14] Shizuo Akira,et al. The roles of TLRs, RLRs and NLRs in pathogen recognition. , 2009, International immunology.
[15] J. Luzio,et al. Delivery of endocytosed membrane proteins to the lysosome. , 2009, Biochimica et biophysica acta.
[16] M. Yoneyama,et al. RNA recognition and signal transduction by RIG‐I‐like receptors , 2009, Immunological reviews.
[17] C. Leifer,et al. TLR9 traffics through the Golgi complex to localize to endolysosomes and respond to CpG DNA , 2008, Immunology and cell biology.
[18] H. Ploegh,et al. Proteolytic cleavage in an endolysosomal compartment is required for activation of Toll-like receptor 9 , 2008, Nature Immunology.
[19] Sarah E. Ewald,et al. The ectodomain of Toll-like receptor 9 is cleaved to generate a functional receptor , 2008, Nature.
[20] George Kollias,et al. Function of TRADD in tumor necrosis factor receptor 1 signaling and in TRIF-dependent inflammatory responses , 2008, Nature Immunology.
[21] Zheng‐gang Liu,et al. The function of TRADD in signaling through tumor necrosis factor receptor 1 and TRIF-dependent Toll-like receptors , 2008, Nature Immunology.
[22] T. Heidmann,et al. Trex1 Prevents Cell-Intrinsic Initiation of Autoimmunity , 2008, Cell.
[23] H. Wagner. The sweetness of the DNA backbone drives Toll-like receptor 9. , 2008, Current opinion in immunology.
[24] Osamu Takeuchi,et al. Sequential control of Toll-like receptor–dependent responses by IRAK1 and IRAK2 , 2008, Nature Immunology.
[25] J. Tschopp,et al. IRAK2 takes its place in TLR signaling , 2008, Nature Immunology.
[26] D. Davies,et al. Structural Basis of Toll-Like Receptor 3 Signaling with Double-Stranded RNA , 2008, Science.
[27] K. Miyake,et al. Roles for LPS-dependent interaction and relocation of TLR4 and TRAM in TRIF-signaling. , 2008, Biochemical and biophysical research communications.
[28] E. Latz,et al. The DNA sugar backbone 2' deoxyribose determines toll-like receptor 9 activation. , 2008, Immunity.
[29] K. Miyake,et al. Cathepsins are required for Toll-like receptor 9 responses. , 2008, Biochemical and biophysical research communications.
[30] H. Ploegh,et al. UNC93B1 delivers nucleotide-sensing toll-like receptors to endolysosomes , 2008, Nature.
[31] E. Caron,et al. Molecular mechanisms of phagocytic uptake in mammalian cells , 2008, Cellular and Molecular Life Sciences.
[32] S. Akira,et al. TRAM couples endocytosis of Toll-like receptor 4 to the induction of interferon-β , 2008, Nature Immunology.
[33] K. Miyazono,et al. Cathepsin K-Dependent Toll-Like Receptor 9 Signaling Revealed in Experimental Arthritis , 2008, Science.
[34] D. Barnes,et al. Trex1 Exonuclease Degrades ssDNA to Prevent Chronic Checkpoint Activation and Autoimmune Disease , 2007, Cell.
[35] K. Takatsu,et al. A protein associated with Toll-like receptor (TLR) 4 (PRAT4A) is required for TLR-dependent immune responses , 2007, The Journal of experimental medicine.
[36] J. Hoffmann,et al. The Drosophila systemic immune response: sensing and signalling during bacterial and fungal infections , 2007, Nature Reviews Immunology.
[37] I. Mellman,et al. Plasmacytoid dendritic cells sense self-DNA coupled with antimicrobial peptide , 2007, Nature.
[38] A. Smahi,et al. TLR3 Deficiency in Patients with Herpes Simplex Encephalitis , 2007, Science.
[39] J. Lieberman,et al. Mutations in the gene encoding the 3′-5′ DNA exonuclease TREX1 are associated with systemic lupus erythematosus , 2007, Nature Genetics.
[40] F. Martinon,et al. NALP Inflammasomes: a central role in innate immunity , 2007, Seminars in Immunopathology.
[41] D. Lin,et al. Fen1 mutations result in autoimmunity, chronic inflammation and cancers , 2007, Nature Medicine.
[42] B. Monks,et al. Ligand-induced conformational changes allosterically activate Toll-like receptor 9 , 2007, Nature Immunology.
[43] Myeong Sup Lee,et al. Signaling pathways downstream of pattern-recognition receptors and their cross talk. , 2007, Annual review of biochemistry.
[44] H. Ploegh,et al. The interaction between the ER membrane protein UNC93B and TLR3, 7, and 9 is crucial for TLR signaling , 2007, The Journal of cell biology.
[45] J. Lieberman,et al. A mutation in TREX1 that impairs susceptibility to granzyme A-mediated cell death underlies familial chilblain lupus , 2007, Journal of Molecular Medicine.
[46] A. Iwasaki,et al. In Brief , 2007, Nature Reviews Immunology.
[47] P. Srivastava,et al. Heat shock protein gp96 is a master chaperone for toll-like receptors and is important in the innate function of macrophages. , 2007, Immunity.
[48] B. Monks,et al. Malaria hemozoin is immunologically inert but radically enhances innate responses by presenting malaria DNA to Toll-like receptor 9 , 2007, Proceedings of the National Academy of Sciences.
[49] K. Miyake. Innate immune sensing of pathogens and danger signals by cell surface Toll-like receptors. , 2007, Seminars in immunology.
[50] B. Beutler,et al. Adjuvant-Enhanced Antibody Responses in the Absence of Toll-Like Receptor Signaling , 2006, Science.
[51] Jianyong Wang,et al. The Functional Effects of Physical Interactions among Toll-like Receptors 7, 8, and 9* , 2006, Journal of Biological Chemistry.
[52] Douglas T. Golenbock,et al. Flavivirus Activation of Plasmacytoid Dendritic Cells Delineates Key Elements of TLR7 Signaling beyond Endosomal Recognition1 , 2006, The Journal of Immunology.
[53] A. Marshak‐Rothstein. Toll-like receptors in systemic autoimmune disease , 2006, Nature Reviews Immunology.
[54] H. Yoshikawa,et al. Chronic polyarthritis caused by mammalian DNA that escapes from degradation in macrophages , 2006, Nature.
[55] Hiroshi Takayanagi,et al. Evidence for licensing of IFN-γ-induced IFN regulatory factor 1 transcription factor by MyD88 in Toll-like receptor-dependent gene induction program , 2006, Proceedings of the National Academy of Sciences.
[56] A. Sher,et al. Cutting Edge: TLR9 and TLR2 Signaling Together Account for MyD88-Dependent Control of Parasitemia in Trypanosoma cruzi Infection1 , 2006, The Journal of Immunology.
[57] R. Coffman,et al. Properties regulating the nature of the plasmacytoid dendritic cell response to Toll-like receptor 9 activation , 2006, The Journal of experimental medicine.
[58] I. Wilson,et al. Details of Toll-like receptor:adapter interaction revealed by germ-line mutagenesis. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[59] D. Barnes,et al. Mutations in the gene encoding the 3′-5′ DNA exonuclease TREX1 cause Aicardi-Goutières syndrome at the AGS1 locus , 2006, Nature Genetics.
[60] F. Weber,et al. Double-Stranded RNA Is Produced by Positive-Strand RNA Viruses and DNA Viruses but Not in Detectable Amounts by Negative-Strand RNA Viruses , 2006, Journal of Virology.
[61] L. Glimcher,et al. Osteopontin expression is essential for interferon-α production by plasmacytoid dendritic cells , 2006, Nature Immunology.
[62] G. Cheng,et al. TRAF3: A New Regulator of Type I Interferons , 2006, Cell cycle.
[63] Zhengfan Jiang,et al. Genetic analysis of host resistance: Toll-like receptor signaling and immunity at large. , 2006, Annual review of immunology.
[64] E. Latz,et al. Endocytic pathways regulate Toll‐like receptor 4 signaling and link innate and adaptive immunity , 2006, The EMBO journal.
[65] Stefan Bauer,et al. CpG motif‐independent activation of TLR9 upon endosomal translocation of “natural” phosphodiester DNA , 2006, European journal of immunology.
[66] S. Grinstein,et al. The Unc93b1 mutation 3d disrupts exogenous antigen presentation and signaling via Toll-like receptors 3, 7 and 9 , 2006, Nature Immunology.
[67] M. Mann,et al. Specificity in Toll-like receptor signalling through distinct effector functions of TRAF3 and TRAF6 , 2006, Nature.
[68] S. Akira,et al. Toll-like receptor–independent gene induction program activated by mammalian DNA escaped from apoptotic DNA degradation , 2005, The Journal of experimental medicine.
[69] S. Akira,et al. RNA-associated autoantigens activate B cells by combined B cell antigen receptor/Toll-like receptor 7 engagement , 2005, The Journal of experimental medicine.
[70] A. DeFranco,et al. TLR3 and TLR7 Are Targeted to the Same Intracellular Compartments by Distinct Regulatory Elements*♦ , 2005, Journal of Biological Chemistry.
[71] D. Davies,et al. The molecular structure of the Toll-like receptor 3 ligand-binding domain. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[72] J. Hawiger,et al. Interactive Sites in the MyD88 Toll/Interleukin (IL) 1 Receptor Domain Responsible for Coupling to the IL1β Signaling Pathway* , 2005, Journal of Biological Chemistry.
[73] Stefan Bauer,et al. Endosomal Translocation of Vertebrate DNA Activates Dendritic Cells via TLR9-Dependent and -Independent Pathways 1 , 2005, The Journal of Immunology.
[74] K. Honda,et al. Spatiotemporal regulation of MyD88–IRF-7 signalling for robust type-I interferon induction , 2005, Nature.
[75] Hideo Negishi,et al. IRF-7 is the master regulator of type-I interferon-dependent immune responses , 2005, Nature.
[76] Tak W. Mak,et al. Integral role of IRF-5 in the gene induction programme activated by Toll-like receptors , 2005, Nature.
[77] V. Hornung,et al. Spontaneous Formation of Nucleic Acid-based Nanoparticles Is Responsible for High Interferon-α Induction by CpG-A in Plasmacytoid Dendritic Cells* , 2005, Journal of Biological Chemistry.
[78] S. Akira,et al. Sequence-specific potent induction of IFN-α by short interfering RNA in plasmacytoid dendritic cells through TLR7 , 2005, Nature Medicine.
[79] Thomas Hartung,et al. CD36 is a sensor of diacylglycerides , 2005, Nature.
[80] E. Fikrig,et al. Toll-like receptor 3 mediates West Nile virus entry into the brain causing lethal encephalitis , 2004, Nature Medicine.
[81] C. Coban,et al. Interferon-α induction through Toll-like receptors involves a direct interaction of IRF7 with MyD88 and TRAF6 , 2004, Nature Immunology.
[82] D. Barnes,et al. Gene-Targeted Mice Lacking the Trex1 (DNase III) 3′→5′ DNA Exonuclease Develop Inflammatory Myocarditis , 2004, Molecular and Cellular Biology.
[83] Hiroyuki Oshiumi,et al. The cytoplasmic 'linker region' in Toll-like receptor 3 controls receptor localization and signaling. , 2004, International immunology.
[84] M. Kruhlak,et al. TLR9 Is Localized in the Endoplasmic Reticulum Prior to Stimulation , 2004, The Journal of Immunology.
[85] S. Akira,et al. TLR9-dependent recognition of MCMV by IPC and DC generates coordinated cytokine responses that activate antiviral NK cell function. , 2004, Immunity.
[86] S. Akira,et al. Toll-like Receptor 9–Dependent and –Independent Dendritic Cell Activation by Chromatin–Immunoglobulin G Complexes , 2004, The Journal of experimental medicine.
[87] Akiko Iwasaki,et al. Recognition of single-stranded RNA viruses by Toll-like receptor 7. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[88] R. Flavell,et al. Toll-like receptors 9 and 3 as essential components of innate immune defense against mouse cytomegalovirus infection. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[89] Shizuo Akira,et al. Innate Antiviral Responses by Means of TLR7-Mediated Recognition of Single-Stranded RNA , 2004, Science.
[90] S. Akira,et al. Species-Specific Recognition of Single-Stranded RNA via Toll-like Receptor 7 and 8 , 2004, Science.
[91] S. Akira,et al. Herpes simplex virus type 1 activates murine natural interferon-producing cells through toll-like receptor 9. , 2004, Blood.
[92] B. Monks,et al. TLR9 signals after translocating from the ER to CpG DNA in the lysosome , 2004, Nature Immunology.
[93] N. Gay,et al. Structural Complementarity of Toll/Interleukin-1 Receptor Domains in Toll-like Receptors and the Adaptors Mal and MyD88* , 2003, Journal of Biological Chemistry.
[94] A. Yamamoto,et al. Subcellular Localization of Toll-Like Receptor 3 in Human Dendritic Cells 1 , 2003, The Journal of Immunology.
[95] Jiahuai Han,et al. Identification of Lps2 as a key transducer of MyD88-independent TIR signalling , 2003, Nature.
[96] Guo-Ping Zhou,et al. Triggering the Interferon Antiviral Response Through an IKK-Related Pathway , 2003, Science.
[97] T. Maniatis,et al. IKKε and TBK1 are essential components of the IRF3 signaling pathway , 2003, Nature Immunology.
[98] Sandra L. Schmid,et al. Regulated portals of entry into the cell , 2003, Nature.
[99] H. Wagner,et al. Human TLR7 or TLR8 independently confer responsiveness to the antiviral compound R-848 , 2002, Nature Immunology.
[100] T. Mak,et al. Severe impairment of interleukin-1 and Toll-like receptor signalling in mice lacking IRAK-4 , 2002, Nature.
[101] M. Shlomchik,et al. Chromatin–IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors , 2002, Nature.
[102] S. Akira,et al. Small anti-viral compounds activate immune cells via the TLR7 MyD88–dependent signaling pathway , 2002, Nature Immunology.
[103] B. Seed,et al. Endoplasmic reticulum chaperone gp96 is required for innate immunity but not cell viability , 2001, Nature Cell Biology.
[104] R. Steinman,et al. Dendritic cells: specialized and regulated antigen processing machines. , 2001, Cell.
[105] T. Horiuchi,et al. Mutation of DNASE1 in people with systemic lupus erythematosus , 2001, Nature Genetics.
[106] S. Akira,et al. Cutting Edge: TLR2-Deficient and MyD88-Deficient Mice Are Highly Susceptible to Staphylococcus aureus Infection1 , 2000, The Journal of Immunology.
[107] T. Möröy,et al. Features of systemic lupus erythematosus in Dnase1-deficient mice , 2000, Nature Genetics.
[108] P. Ricciardi-Castagnoli,et al. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. , 1998, Science.
[109] H. Mischak,et al. CpG‐DNA‐specific activation of antigen‐presenting cells requires stress kinase activity and is preceded by non‐specific endocytosis and endosomal maturation , 1998, The EMBO journal.
[110] B. Lemaître,et al. The Dorsoventral Regulatory Gene Cassette spätzle/Toll/cactus Controls the Potent Antifungal Response in Drosophila Adults , 1996, Cell.
[111] J. F. O'Connor. Psychoses associated with systemic lupus erythematosus. , 1959, Annals of internal medicine.
[112] B. Beutler,et al. The forward genetic dissection of afferent innate immunity. , 2008, Current topics in microbiology and immunology.
[113] R. Medzhitov,et al. Intracellular localization of Toll-like receptor 9 prevents recognition of self DNA but facilitates access to viral DNA , 2006, Nature Immunology.
[114] H. Yoshida,et al. Lethal anemia caused by interferon-β produced in mouse embryos carrying undigested DNA , 2005, Nature Immunology.
[115] I. Mellman. Endocytosis and molecular sorting. , 1996, Annual review of cell and developmental biology.